A loss-of-function genetic screening reveals synergistic targeting of AKT/mTOR and WTN/beta-catenin pathways for treatment of AML with high PRL-3 phosphatase
- Resource Type
- Journal
- Source
JOURNAL OF HEMATOLOGY & ONCOLOGY ; MAR 7 2018, 11 p36 12p.- Subject
- Language
- English
- ISSN
- 17568722